agilon health turns to Q2 FY26 profit of $18 million; revenue rises 7% to $1.49 billion
Reuters2026/08/05 20:23- agilon health reported Q2 2026 net income of USD 18 million, reversing a USD 104 million loss a year earlier.
- Revenue rose 7% year over year to USD 1.49 billion, despite total members falling 10% to 549,000.
- Adjusted EBITDA turned positive to USD 70 million from a USD 83 million loss, while medical margin swung to USD 197 million.
- Raised FY2026 guidance for revenue to USD 5.78-5.86 billion, adjusted EBITDA to USD 75-95 million, medical margin to USD 465-505 million.
- CEO Tim O’Rourke cited stronger burden-of-illness execution, favorable medical cost trends, operating discipline; membership declines tied to contracting focus, exits, measured growth.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
OPEC+ agrees to keep oil output policy unchanged for October
US military strikes Iranian oil tanker, triggering geopolitical risks as Brent crude nears $97 mark
Following the US military's attack on Iranian oil tankers and Iran's announcement of new restricted navigation zones outside the Strait of Hormuz, market concerns over prolonged disruptions in key energy transport routes have intensified, leading to a sharp rise in international oil prices.
Geopolitical tensions overshadowing production cuts: OPEC+ maintains quotas unchanged, paper adjustments fail to resolve physical supply dilemmas
OPEC+ major oil producers, led by Saudi Arabia and Russia, held a monthly video conference last Sunday and decided to keep the crude oil production quota for October unchanged, continuing the previous tone of stable production following a series of symbolic production increases.
IX Biopharma seeks SGX-ST trading halt lift for shares in Singapore
Crypto prices
More
